LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence

INTRODUCTION: Methamphetamine dependence is a growing public health concern. There is currently no pharmacotherapy approved for methamphetamine dependence. Lisdexamfetamine (LDX) dimesylate, used in the treatment of attention-deficit hyperactivity disorder and binge eating disorder, has potential as...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMJ Open
Hoofdauteurs: Ezard, Nadine, Dunlop, Adrian, Hall, Michelle, Ali, Robert, McKetin, Rebecca, Bruno, Raimondo, Phung, Nghi, Carr, Andrew, White, Jason, Clifford, Brendan, Liu, Zhixin, Shanahan, Marian, Dolan, Kate, Baker, Amanda L, Lintzeris, Nicholas
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Publishing Group 2018
Onderwerpen:
Addiction
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059315/
https://ncbi.nlm.nih.gov/pubmed/30030312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-020723
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items